Last update 20 Jun 2025

SWA1211

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
SWA1211
Target
HPK1
Action
inhibitors
Mechanism
HPK1 inhibitors(Mitogen-activated protein kinase kinase kinase kinase 1 inhibitors)
Therapeutic Areas
Neoplasms
Active Indication
Advanced Malignant Solid NeoplasmNeoplasms
Inactive Indication-
Originator Organization
Beijing Wangshi Intelligent Technology Co., Ltd.
Active Organization
Beijing Wangshi Intelligent Technology Co., Ltd.Beijing Stonewise Technology Co., Ltd.Beijing Stonewise Technology Co., Ltd.
Inactive Organization-
License Organization-
Drug Highest PhasePhase 1
First Approval Date-
Regulation-
Login to view timeline

Related

1
Clinical Trials associated with SWA1211
CTR20251571
/ RecruitingPhase 1
一项评价SWA1211片在晚期实体瘤患者中的安全性、耐受性、药代动力学特征及初步疗效的首次人体、开放标签的I期临床研究
[Translation] A first-in-human, open-label, Phase I clinical study evaluating the safety, tolerability, pharmacokinetic characteristics and preliminary efficacy of SWA1211 tablets in patients with advanced solid tumors
100 Clinical Results associated with SWA1211
Login to view more data
100 Translational Medicine associated with SWA1211
Login to view more data
100 Patents (Medical) associated with SWA1211
Login to view more data
100 Deals associated with SWA1211
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Advanced Malignant Solid NeoplasmPhase 1
China
Beijing Wangshi Intelligent Technology Co., Ltd.
05 Jun 2025
NeoplasmsPreclinical
China
Beijing Stonewise Technology Co., Ltd.Beijing Stonewise Technology Co., Ltd.
29 Apr 2025
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free